Patents and public health: legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Baden-Baden
Nomos
2009
|
| Ausgabe: | 1. Aufl. |
| Schriftenreihe: | MIPLC studies
3 |
| Schlagworte: | |
| Online-Zugang: | Volltext Inhaltsverzeichnis |
| Beschreibung: | 291 S. |
| ISBN: | 9783832940782 |
| DOI: | 10.5771/9783845212654 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV035235724 | ||
| 003 | DE-604 | ||
| 005 | 20240529 | ||
| 007 | t | ||
| 008 | 090108s2009 gw m||| 00||| eng d | ||
| 015 | |a 08,N46,0412 |2 dnb | ||
| 016 | 7 | |a 991006232 |2 DE-101 | |
| 020 | |a 9783832940782 |c Pb. : ca. sfr 115.00 (freier Pr.), ca. EUR 68.00 |9 978-3-8329-4078-2 | ||
| 024 | 3 | |a 9783832940782 | |
| 035 | |a (OCoLC)299688110 | ||
| 035 | |a (DE-599)DNB991006232 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-M382 |a DE-384 |a DE-703 |a DE-19 |a DE-12 |a DE-355 |a DE-20 |a DE-188 |a DE-473 |a DE-859 |a DE-521 |a DE-634 |a DE-1051 |a DE-706 |a DE-739 |a DE-1046 |a DE-860 | ||
| 050 | 0 | |a K3636 | |
| 082 | 0 | |a 344.04233 |2 22 | |
| 084 | |a PR 2352 |0 (DE-625)139575: |2 rvk | ||
| 084 | |a 340 |2 sdnb | ||
| 100 | 1 | |a Law, Andrew |d 1972- |e Verfasser |0 (DE-588)137109431 |4 aut | |
| 245 | 1 | 0 | |a Patents and public health |b legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 |c Andrew Law |
| 250 | |a 1. Aufl. | ||
| 264 | 1 | |a Baden-Baden |b Nomos |c 2009 | |
| 300 | |a 291 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a MIPLC studies |v 3 | |
| 502 | |b Dissertation |c Universität München |d 2008 | ||
| 630 | 0 | 4 | |a Agreement on Trade-Related Aspects of Intellectual Property Rights |d (1994) |
| 630 | 0 | 7 | |a Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum |f 1994 April 15 |0 (DE-588)4450013-0 |2 gnd |9 rswk-swf |
| 650 | 4 | |a Entwicklungsländer | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drugs |x Law and legislation |z Developing countries | |
| 650 | 4 | |a Drugs |x Patents | |
| 650 | 4 | |a Intellectual property (International law) | |
| 650 | 4 | |a Public health |z Developing countries | |
| 650 | 0 | 7 | |a Zwangslizenz |0 (DE-588)4191193-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Patentschutz |0 (DE-588)4173537-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz | |
| 651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 0 | 1 | |a Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum |f 1994 April 15 |0 (DE-588)4450013-0 |D u |
| 689 | 0 | 2 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 3 | |a Patentschutz |0 (DE-588)4173537-7 |D s |
| 689 | 0 | 4 | |a Zwangslizenz |0 (DE-588)4191193-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-3-8452-1265-4 |
| 830 | 0 | |a MIPLC studies |v 3 |w (DE-604)BV035044599 |9 3 | |
| 856 | 4 | 1 | |u http://doi.org/10.5771/9783845212654 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017041583&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 912 | |a ZDB-18-NEA |a ebook | ||
Datensatz im Suchindex
| _version_ | 1805074298590724096 |
|---|---|
| adam_text |
Table
of
Contents
Chapter
1
Introduction
17
Chapter
2
Patents and society
19
Chapter
3
The legalising policy thoughts in the Public Health Declaration
26
Chapter
4
The circumstances leading up to the Public Health Declaration
29
A. Introduction
29
B. The events preceding the Public Health Declaration
30
I. The
GATT
system and the Uruguay Round
30
II. The implementation of the TRIPS Agreement
34
Chapters An analysis of the TRIPS Agreement
42
A. Nature and scope of the TRIPS Agreement
42
B. The object and purpose of the TRIPS Agreement
47
I. An analysis of the preamble
48
II. An analysis of Article
7
TRIPS
51
III. An analysis of Article
8.1
TRIPS
53
IV. An analysis of Article
8.2
TRIPS Agreement
56
V. The influence of the international customary rule of interpretation on
the object and purpose provisions
58
VI. The role of 'flexibility' in the object and purposes of the TRIPS
Agreement
60
1.
The flexibilities found in the object and purposes provisions
61
2.
The role of the object and purpose provisions in flexibilities found
in other TRIPS provision
62
3.
The relevance given to the role of flexibility in the object and
purpose provisions by the Member States
63
VII.
The role of health in the object and purpose of the TRIPS Agreement
65
VIII.
Other influences on the object and purpose of the
TRIPS Agreement
68
C. The material provisions of the TRIPS Agreement
69
I. The subject matter of patents
69
1.
Article
27.1
of the TRIPS Agreement
70
2.
Article
27.2
of the TRIPS Agreement
71
a) Commercial exploitation
72
b) Necessity
75
c) Discrimination and differentiation
81
d) Implementation restrictions relating to the Article
27.2
exclusion
83
3.
Conclusion
84
II. Rights conferred to the
patent
holder
85
III. The withdrawal and limitation of rights conferred
86
1.
Revocation
87
2.
Limited exceptions
90
3.
Compulsory licenses
101
a) General 1°1
aa) The compulsory license system
101
bb) Grounds for compulsory licenses
102
cc) Discrimination
105
dd) Causality approach
106
ее)
The relationship between Article
31
of the TRIPS
Agreement and Article
5
A(4) of the Paris Convention
107
ff) Commercial use of compulsory licenses
108
b) Article 31(a)
108
c) Article
31
(b), first sentence
110
d) Article
3
l(b), second sentence
112
aa) Extreme urgencies and national emergencies
113
bb) Public non-commercial use
117
e) Article
31
(c)
121
aa) Scope
121
bb) Duration
123
í)
Article 31(d)
124
g) Article
31
(e)
126
h) Article
31
(f)
127
i) Article
31
(g)
131
j) Article 31(h)
134
k) Article 31(i and j)
141
1)
Article
31
(k)
144
m) Conclusion
144
IV. Disclosure
145
V. Exhaustion
149
D. Conclusion
154
Chapter
6
The Public Health Declaration
156
A. The scope of the Public Health Declaration
156
I
.
Clarification of the relationship between the TRIPS Agreement and
public health
157
II. Countries without domestic productions facilities
159
III. The postponed implementation of certain TRIPS-obligations
160
B. The legal status of the Public Health Declaration
161
C. The effect of the Public Health Declaration on the TRIPS Agreement
163
I. The scope and purpose
163
1.
The customary rales of interpretation
164
2.
The Public Health Declaration and Articles
7
and
8
of the
TRIPS Agreement
165
10
3.
The Public Health Declaration and the right to health
167
4.
Conclusion
169
II. The material obligations
169
1.
Exhaustion
169
2.
Compulsory licenses
170
a) The flexibilities in paragraph
5
of the Public Health
Declaration
171
b) Paragraph 5(b) of the Public Health Declaration
172
c) Paragraph 5(c) of the Public Health Declaration
174
d) Subsequent developments
177
e) Conclusion
178
III. The extension of the transitional period for LDCs
178
1.
Paragraph
7
of the Public Health Declaration
178
2.
The TRIPS Council decision extending the transition period
182
3.
The General Council waiver of Article
70.9 183
IV. Member States without domestic pharmaceutical production facilities
185
Chapter
7
The solution to the paragraph
6
dilemma
186
A. The identification of the paragraph
6
issues
186
I. The scope of paragraph
6 186
II. Manufacturing capacity
187
III. Insufficient or no capacities
188
IV. Pharmaceutical sector
188
V. Effective use of the compulsory license system
189
VI. Potential paragraph
6
solutions
189
B. The
30
August
2003
decision
190
I. The legal effect of the Decision and the Chairman's Statement
191
1.
The waivers in the Decision
191
2.
The Decision's moratorium
192
3.
The Chairman's Statement
193
II. The scope of the Decision
197
III. The legal implications of the Decision
198
1.
The pharmaceutical product
198
2.
Eligible countries
201
a) The exporting Member State
201
b) The importing Member State
204
c) Conclusion
210
3.
Safeguards
210
a) Safeguards inherent to the system
211
b) General safeguards
214
4.
Transfer of technology
216
IV. Procedure for the adoption of a final solution
217
С
Article
31
bis of the TRIPS Agreement
218
11
Chapter
8
The realisation opportunities afforded by the Public
Health Declaration
223
A. Norway
223
B. Canada
228
С
The Netherlands
234
D. India
236
C. ЕС
238
F. Related measures taken to reflect the Public Health Declaration
242
I. International and multilateral policies and measures
242
II. Bilateral policies and measures
242
III. National policies and measures
245
G. Conclusion
247
Chapter
9
Dennitive consequences of the Public Health Declaration
248
Bibliography
251
Cited treaties, legislation and similar legal documents
262
Cited cases
268
Annex I: Public Health Declaration
272
Annex II:
30
August
2003
Decision
275
Annex III: The Article
ЗШѕ
Amendment
282
Annex IV: Examples of royalty rates in compulsory licensing
&
related cases
291
12 |
| any_adam_object | 1 |
| author | Law, Andrew 1972- |
| author_GND | (DE-588)137109431 |
| author_facet | Law, Andrew 1972- |
| author_role | aut |
| author_sort | Law, Andrew 1972- |
| author_variant | a l al |
| building | Verbundindex |
| bvnumber | BV035235724 |
| callnumber-first | K - Law |
| callnumber-label | K3636 |
| callnumber-raw | K3636 |
| callnumber-search | K3636 |
| callnumber-sort | K 43636 |
| callnumber-subject | K - General Law |
| classification_rvk | PR 2352 |
| collection | ZDB-18-NEA ebook |
| ctrlnum | (OCoLC)299688110 (DE-599)DNB991006232 |
| dewey-full | 344.04233 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 344 - Labor, social, education & cultural law |
| dewey-raw | 344.04233 |
| dewey-search | 344.04233 |
| dewey-sort | 3344.04233 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| doi_str_mv | 10.5771/9783845212654 |
| edition | 1. Aufl. |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV035235724</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240529</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090108s2009 gw m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">08,N46,0412</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">991006232</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783832940782</subfield><subfield code="c">Pb. : ca. sfr 115.00 (freier Pr.), ca. EUR 68.00</subfield><subfield code="9">978-3-8329-4078-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783832940782</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)299688110</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB991006232</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-634</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-860</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">K3636</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">344.04233</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PR 2352</subfield><subfield code="0">(DE-625)139575:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">340</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Law, Andrew</subfield><subfield code="d">1972-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)137109431</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patents and public health</subfield><subfield code="b">legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001</subfield><subfield code="c">Andrew Law</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. Aufl.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Baden-Baden</subfield><subfield code="b">Nomos</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">291 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">MIPLC studies</subfield><subfield code="v">3</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Universität München</subfield><subfield code="d">2008</subfield></datafield><datafield tag="630" ind1="0" ind2="4"><subfield code="a">Agreement on Trade-Related Aspects of Intellectual Property Rights</subfield><subfield code="d">(1994)</subfield></datafield><datafield tag="630" ind1="0" ind2="7"><subfield code="a">Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum</subfield><subfield code="f">1994 April 15</subfield><subfield code="0">(DE-588)4450013-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intellectual property (International law)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public health</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zwangslizenz</subfield><subfield code="0">(DE-588)4191193-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentschutz</subfield><subfield code="0">(DE-588)4173537-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum</subfield><subfield code="f">1994 April 15</subfield><subfield code="0">(DE-588)4450013-0</subfield><subfield code="D">u</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Patentschutz</subfield><subfield code="0">(DE-588)4173537-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Zwangslizenz</subfield><subfield code="0">(DE-588)4191193-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-8452-1265-4</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">MIPLC studies</subfield><subfield code="v">3</subfield><subfield code="w">(DE-604)BV035044599</subfield><subfield code="9">3</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://doi.org/10.5771/9783845212654</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017041583&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-18-NEA</subfield><subfield code="a">ebook</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| geographic | Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz Entwicklungsländer (DE-588)4014954-7 gnd |
| geographic_facet | Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz Entwicklungsländer |
| id | DE-604.BV035235724 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-20T05:23:17Z |
| institution | BVB |
| isbn | 9783832940782 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017041583 |
| oclc_num | 299688110 |
| open_access_boolean | 1 |
| owner | DE-M382 DE-384 DE-703 DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-20 DE-188 DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-739 DE-1046 DE-860 |
| owner_facet | DE-M382 DE-384 DE-703 DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-20 DE-188 DE-473 DE-BY-UBG DE-859 DE-521 DE-634 DE-1051 DE-706 DE-739 DE-1046 DE-860 |
| physical | 291 S. |
| psigel | ZDB-18-NEA ebook |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Nomos |
| record_format | marc |
| series | MIPLC studies |
| series2 | MIPLC studies |
| spelling | Law, Andrew 1972- Verfasser (DE-588)137109431 aut Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 Andrew Law 1. Aufl. Baden-Baden Nomos 2009 291 S. txt rdacontent n rdamedia nc rdacarrier MIPLC studies 3 Dissertation Universität München 2008 Agreement on Trade-Related Aspects of Intellectual Property Rights (1994) Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd rswk-swf Entwicklungsländer Recht Drugs Law and legislation Developing countries Drugs Patents Intellectual property (International law) Public health Developing countries Zwangslizenz (DE-588)4191193-3 gnd rswk-swf Patentschutz (DE-588)4173537-7 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Entwicklungsländer (DE-588)4014954-7 g Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 u Arzneimittel (DE-588)4003115-9 s Patentschutz (DE-588)4173537-7 s Zwangslizenz (DE-588)4191193-3 s DE-604 Erscheint auch als Online-Ausgabe 978-3-8452-1265-4 MIPLC studies 3 (DE-604)BV035044599 3 http://doi.org/10.5771/9783845212654 Verlag kostenfrei Volltext Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017041583&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Law, Andrew 1972- Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 MIPLC studies Agreement on Trade-Related Aspects of Intellectual Property Rights (1994) Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd Entwicklungsländer Recht Drugs Law and legislation Developing countries Drugs Patents Intellectual property (International law) Public health Developing countries Zwangslizenz (DE-588)4191193-3 gnd Patentschutz (DE-588)4173537-7 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4450013-0 (DE-588)4191193-3 (DE-588)4173537-7 (DE-588)4003115-9 (DE-588)4014954-7 (DE-588)4113937-9 |
| title | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 |
| title_auth | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 |
| title_exact_search | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 |
| title_full | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 Andrew Law |
| title_fullStr | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 Andrew Law |
| title_full_unstemmed | Patents and public health legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 Andrew Law |
| title_short | Patents and public health |
| title_sort | patents and public health legalising the policy thoughts in the doha trips declaration of 14 november 2001 |
| title_sub | legalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 |
| topic | Agreement on Trade-Related Aspects of Intellectual Property Rights (1994) Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 (DE-588)4450013-0 gnd Entwicklungsländer Recht Drugs Law and legislation Developing countries Drugs Patents Intellectual property (International law) Public health Developing countries Zwangslizenz (DE-588)4191193-3 gnd Patentschutz (DE-588)4173537-7 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Agreement on Trade-Related Aspects of Intellectual Property Rights (1994) Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum 1994 April 15 Entwicklungsländer Recht Drugs Law and legislation Developing countries Drugs Patents Intellectual property (International law) Public health Developing countries Zwangslizenz Patentschutz Arzneimittel Entwicklungsländer - Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum - Arzneimittel - Patentschutz - Zwangslizenz Hochschulschrift |
| url | http://doi.org/10.5771/9783845212654 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017041583&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV035044599 |
| work_keys_str_mv | AT lawandrew patentsandpublichealthlegalisingthepolicythoughtsinthedohatripsdeclarationof14november2001 |